Numinus Wellness Inc (FRA:LR23)
€ 0.0145 -0.0029 (-16.67%) Market Cap: 5.30 Mil Enterprise Value: 7.53 Mil PE Ratio: 0 PB Ratio: 2.14 GF Score: 0/100

Q4 2022 Numinus Wellness Inc Earnings Call Transcript

Nov 29, 2022 / 10:30PM GMT
Release Date Price: €0.175
Operator

Good afternoon, and welcome to Numinus Wellness Inc.'s Fiscal Fourth Quarter and Annual 2022 Results Conference Call. A question-and-answer session for analysts and institutional investors will follow the formal remarks. As a reminder, this call is being recorded.

I would now like to turn the conference call over to your host, Jamie Kokoska, Vice President of Investor Relations. Please proceed.

Jamie Kokoska
Numinus Wellness Inc. - VP of IR

Thank you, Brent. Good afternoon, everyone, and thank you for joining us for our fiscal fourth quarter and annual 2022 results conference call. Discussing Numinus' performance today are Payton Nyquvest, Founder and CEO; and John Fong, Chief Financial Officer. Joining them for analyst questions at the end of our formal remarks are Reid Robison, Chief Clinical Officer; and Paul Thielking, Chief Science Officer.

The following discussion may include forward-looking statements that are based on current expectations and are subject to a number of risks and uncertainties. The risks and uncertainties that could

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot